Impact of Interventions on Medication Adherence and Blood Pressure Control in Patients with Essential Hypertension: A Systematic Review by the ISPOR Medication Adherence & Persistence Special Interest Group

Impact of Interventions on Medication Adherence and Blood Pressure Control in Patients with Essential Hypertension: A Systematic Review by the ISPOR Medication Adherence & Persistence Special Interest Group

The citation for this paper is:
Gwadry-Sridhar FH, Manias E, Lai L, et al. Impact of Interventions on Medication Adherence and Blood Pressure Control in Patients with Essential Hypertension: A Systematic Review. Value Health 2013; 16: 863-871.

Developed by the Medication Adherence & Persistence Special Interest Group

Chair:
Femida Gwadry-Sridhar, PhD, RPh, MSc, Assistant Professor, Departments of Medicine, Physiology and Pharmacology, and Computer Science, University of Western Ontario; Associate Director, Critical Care Research Network; Director of Health Informatics, Lawson Health Research Institute; CIHR New Investigator-Knowledge Translation, London, Ontario, Canada

Leadership Group:
Maja Grubisic, BSc, MSc
Dyfrig Hughes, PhD, MSc, Professor of Pharmacoeconomics, Bangor University Centre for Health Economics and Medicines Evaluation, IMSCaR, Bangor University, Wales, UK
Lincy Lal, Pharm.D, PhD, Senior Research Consultant – Healthcare, Ingenix Consulting, Missouri City, TX, USA
Elizabeth Manias RN, BPharm, MPharm, MNStud, PhD, FRCNA, MPS, Professor, Associate Head of Research, School of Nursing and Social Work, Faculty of Medicine, Dentistry and Health Sciences, The University of Melbourne, Carlton, Victoria, Australia
Alexandria Ratzki-Leewing, BHSc
Maribel Salas MD, DSc, MSc, FACP, Medical Director, US Patient Safety, AstraZeneca, Wilmington, DE and CCEB, University of Pennsylvania, Philadelphia PA, USA


ISPOR GOOD RESEARCH PRACTICES INDEX